HEPCLUDEX
Live / Registered — Registered (as of 05 Jan 2021)
What this means for you
Registered since 05 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79279863
- Registration number
- 6235919
- Mark type
- Stylized text
- Filed
- 27 Dec 2019
- Published for opposition
- 20 Oct 2020
- Registered
- 05 Jan 2021
- Attorney of record
- Megan K. Bowen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations in the nature of diagnostic preparations for veterinary and medical purposes; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for veterinary purposes, namely, for the treatment of intestinal bacteria; biochemical preparations for medical purposes, namely, for treating chemical imbalances; biochemical preparations for veterinary purposes, namely, nucleic acid sequences and chemical reagents for veterinary purposes; chemical preparations for medical purposes, namely, for diagnosis of pregnancy; chemical preparations for veterinary purposes in the nature of chemical reagents for veterinary purposes; medicines for human purposes, namely, for treating intestinal disorders; medicines for veterinary purposes, namely, for treating intestinal disorders; pharmaceutical preparations for the treatment of hepatic diseases or disorders; pharmaceutical preparations for the treatment of hepatitis B; pharmaceutical preparations for the treatment of hepatitis D; pharmaceutical preparations for the treatment of dyslipidemia; pharmaceutical preparations for the treatment of nonalcoholic steatohepatitis (NASH); pharmaceutical preparations for the treatment of primary biliary cholangitis (PBC); pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide (NTCP); pharmaceutical preparations for the treatment of metabolic diseases; and pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide (NTCP)
Owner
Prosecution history
- 05 Jan 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Feb 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 27 May 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 06 Nov 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 02 Oct 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 02 May 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 08 Apr 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 08 Apr 2021 — FINAL DISPOSITION PROCESSED
- 05 Apr 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Mar 2021 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
- 20 Feb 2021 — CORRECTION TRANSACTION RECEIVED FROM IB
- 22 Jan 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 05 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Oct 2020 — PUBLISHED FOR OPPOSITION